The Morgan Stanley Global Healthcare Conference: Amgen’s presentation

THOUSAND OAKS, California: The Morgan Stanley Global Healthcare Conference scheduled for Tuesday, Sept. 13, 2011 at the Grand Hyatt in New York City will include a presentation by Amgen (NASDAQ: AMGN) commencing 9:10 AM EST. Senior vice president of North America Commercial Operations at Amgen, Jim Daly, is said to present at the conference. Live audio of the presentation will be made available at the company’s website: www.amgen.com.

About Amgen
A biotechnology pioneer since 1980, Amgen is involved in the discovery, development, manufacture, and delivery of innovative human therapeutics. Amgen was one of the earliest companies to enable the transition of safe, effective medicines from lab to manufacturing plant to patient, thereby realizing the promise of new science. By helping the world to battle serious ailments like cancer, kidney disease, rheumatoid arthritis, bone disease, and others, Amgen therapeutics have changed the practice of medicine. Amgen continues its commitment to advance science for the betterment of people with a deep and broad pipeline of potential new medicines.